Mediterranean Diet, Exercise and Dementia Risk in UK Adults

NCT ID: NCT03673722

Last Updated: 2023-12-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

108 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-04-01

Study Completion Date

2023-09-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In cohort studies, a Mediterranean Dietary Pattern (MDP) has been consistently associated with reduced dementia incidence. The efficacy of a MDP to prevent dementia has never been directly demonstrated by RCTs, with existing research limited to cognition as a secondary outcome. Furthermore, despite their likely additive effects, the combined impact of Physical Activity (PA) and a MDP on dementia risk is unknown.

MedEx-UK is a RCT that will evaluate the feasibility of a multi-domain intervention to increase Mediterranean Dietary Pattern (MDP) adherence and physical activity (PA) in a group of older UK adults who are at above average risk of dementia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In MedEx-UK the investigators propose to conduct a feasibility study in three UK centres (Norwich, Birmingham, Newcastle) which collectively will recruit 108 UK older adults (55-74y) who are at above average risk of dementia, but pre-clinical. Primary outcome is to evaluate the feasibility of a multi-domain intervention to increase MDP adherence and PA over a 24 week period, and to demonstrate the possibility of achieving meaningful behavioural change in a UK population. Secondary outcomes will be to measure the sensitivity of various cognitive assessments and measure the variability of our primary and secondary outcome measures in this population at baseline and in response to intervention.

There are three intervention arms to the study, and participants will be randomised with minimisation for gender and Mediterranean Diet Adherence Screener score (MEDAS; a validated questionnaire)

1. MDP:

Participants will be asked to alter their consumption of foods consistent with a Mediterranean Diet. Examples include increased intake of fruits and vegetables, nuts, olive oil as the main culinary fat, moderate wine consumption (if they already consume alcohol), preferring white meat over red, and a reduction in commercial sweet and pastries, and sugar-sweetened drinks.
2. MDP plus PA:

As well as the dietary intervention as in 1., participants will be asked to increase their PA using a mixture of structured (e.g. dancing, Zumba classes, swimming etc.) and non-structured (walking up stairs, gardening etc.) activities.
3. Control:

Participants will be given generic healthy eating advice based on the NHS 'Eatwell' plate and UK British Heart Foundation (BHF) guidelines.

The overall purpose of this study is to inform the feasibility and design of a future large-scale UK dementia risk reduction RCT, to observe whether a multi-domain intervention over 2 to 5 years promoting MDP adherence and increased PA can reduce cognitive decline and brain atrophy in adults at above average risk of dementia.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dementia

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Mediterranean Diet Physical Activity Dementia Alzheimer Disease Cognition

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

RCT
Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

MDP only

Participants will be asked to increase their consumption of foods that are consistent with a Mediterranean Dietary Pattern through interaction with the online LEAP2 platform

Group Type EXPERIMENTAL

Foods consistent with a MDP

Intervention Type OTHER

We aim to increase MDP by 3 points, according to a 14-point MEDAS score

MDP plus PA

Participants will be asked to increase their consumption of foods that are consistent with a Mediterranean Dietary Pattern AND to increase Physical Activity using a mixture of structured and non-structured activities through interaction with the online LEAP2 platform

Group Type EXPERIMENTAL

Foods consistent with a MDP

Intervention Type OTHER

We aim to increase MDP by 3 points, according to a 14-point MEDAS score

Physical Activity

Intervention Type OTHER

We aim to increase PA to 150 minutes moderate activity per week.

Control

Participants will be given generic healthy eating advice based on the NHS 'Eatwell' plate and British Heart Foundation (BHF) guidelines

Group Type PLACEBO_COMPARATOR

Control

Intervention Type OTHER

Participants will be given generic healthy eating advice based

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Foods consistent with a MDP

We aim to increase MDP by 3 points, according to a 14-point MEDAS score

Intervention Type OTHER

Physical Activity

We aim to increase PA to 150 minutes moderate activity per week.

Intervention Type OTHER

Control

Participants will be given generic healthy eating advice based

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male and female, aged 55-74 years
* Understands and is willing and able to comply with all study procedures, including changes to diet and physical activity levels
* Access to, and able to use, the internet/computer/tablet device
* QRISK3 score of \>=15 (assessed by GP)
* Subjective Memory Complaints (SMC), based on a score of \>16 on the Cognitive Change Index (CCI) (from the first 12 items)
* Stable use of any prescribed medication for at least four weeks
* Normal (or corrected to normal) vision and hearing
* Fluent in written and spoken English
* Willing and able to provide written informed consent

Exclusion Criteria

* Diagnosis of Alzheimer's disease (AD), other form of dementia, Mild Cognitive Impairment (MCI), or significant neurological disorder
* Cognition not within normal range, based on a score of \<26 on the Montreal Cognitive Assessment (MoCA); or an indication of cognitive decline, based on a score of ≥2 on Ascertain Dementia (AD-8)
* Evidence of impairment of Instrumental Activities of Daily living (IADLS)
* Moderate to severe depression, assessed by the Patient Health Questionnaire (PHQ-9), a score of \>10 being exclusionary
* Moderate to severe anxiety, assessed by the Generalised Anxiety Disorder Assessment (GAD-7), a score of \>10 being exclusionary
* Current psychotic illness (delusional disorder/schizophrenia)
* History of serious mental illness know to affect cognition (schizophrenia, schizoaffective disorder, bipolar disorder)
* Subjects with other clinically diagnosed psychiatric disorders likely to affect the cognitive measures (as judged by a clinical advisor)
* HIV positive
* Past history or previous MRI evidence of brain damage, significant head trauma (including loss of consciousness as a result), brain surgery, stroke, or serious neurological disorders
* History of alcohol or drug dependency in the last 2 years
* Subjects with existing diagnosed gastrointestinal disorders likely to impact study results (as judged by a clinical advisor)
* History of any major cardiovascular event, such as a myocardial infarction, stroke or TIA
* Diagnosed COPD
* Cancer, or cancer/treatment within the last 12 months
* Diagnosis of type 1 or type 2 diabetes \< 3 months ago
* Clinical diagnosis of liver or kidney disease
* Diagnosed Epilepsy
* Subjects with any other existing medical conditions likely to affect the study measures
* BMI \>40kg/m2
* A habitual Mediterranean Diet Score (MDS) ≥9
* Habitual physical activity of \>60 minutes moderate activity per week, assessed using the International Physical Activity Questionnaire (IPAQ), short form
* Currently actively engaged in a weight loss, other dietary, or physical activity intervention
* Prescribed medications likely to influence the study measures (as judged by a clinical advisor)
* Currently a participant or have participated in any other study involving an investigational product in the last 4 weeks
* Metal implants, e.g. pacemaker that precludes MRI.
* Claustrophobic which precludes MRI scanning.
Minimum Eligible Age

55 Years

Maximum Eligible Age

74 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of East Anglia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Anne Marie Minihane, PhD

Role: PRINCIPAL_INVESTIGATOR

University of East Anglia

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Birmingham

Birmingham, , United Kingdom

Site Status

Newcastle University

Newcastle upon Tyne, , United Kingdom

Site Status

University of East Anglia

Norwich, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Jennings A, Shannon OM, Gillings R, Lee V, Elsworthy R, Bundy R, Rao G, Hanson S, Hardeman W, Paddick SM, Siervo M, Aldred S, Mathers JC, Hornberger M, Minihane AM. Effectiveness and feasibility of a theory-informed intervention to improve Mediterranean diet adherence, physical activity and cognition in older adults at risk of dementia: the MedEx-UK randomised controlled trial. BMC Med. 2024 Dec 23;22(1):600. doi: 10.1186/s12916-024-03815-z.

Reference Type DERIVED
PMID: 39716203 (View on PubMed)

Elsworthy RJ, Jong ST, Hanson S, Shannon OM, Jennings A, Gillings R, Siervo M, Hornberger M, Hardeman W, Mathers JC, Minihane AM, Aldred S. Effects of the COVID-19 associated United Kingdom lockdown on physical activity in older adults at high risk of cardiovascular disease: a mixed methods perspective from the MedEx-UK multicenter trial. Front Public Health. 2024 May 9;12:1371453. doi: 10.3389/fpubh.2024.1371453. eCollection 2024.

Reference Type DERIVED
PMID: 38784572 (View on PubMed)

Shannon OM, Lee V, Bundy R, Gillings R, Jennings A, Stephan B, Hornberger M, Balanos G, Paddick SM, Hanson S, Hardeman W, Holmes R, Garner N, Aldred S, Siervo M, Mathers JC, Minihane AM. Feasibility and acceptability of a multi-domain intervention to increase Mediterranean diet adherence and physical activity in older UK adults at risk of dementia: protocol for the MedEx-UK randomised controlled trial. BMJ Open. 2021 Feb 5;11(2):e042823. doi: 10.1136/bmjopen-2020-042823.

Reference Type DERIVED
PMID: 33550254 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ARUK-PRRF2017-006UK

Identifier Type: -

Identifier Source: org_study_id